Literature DB >> 21720379

iPSCs: Unstable origins?

Sayandip Mukherjee1, Adrian J Thrasher.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21720379      PMCID： PMC3129555          DOI： 10.1038/mt.2011.116

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  33 in total

1.  Generation of induced pluripotent stem cells using recombinant proteins.

Authors:  Hongyan Zhou; Shili Wu; Jin Young Joo; Saiyong Zhu; Dong Wook Han; Tongxiang Lin; Sunia Trauger; Geoffery Bien; Susan Yao; Yong Zhu; Gary Siuzdak; Hans R Schöler; Lingxun Duan; Sheng Ding
Journal:  Cell Stem Cell       Date:  2009-04-23       Impact factor: 24.633

2.  A combined chemical and genetic approach for the generation of induced pluripotent stem cells.

Authors:  Yan Shi; Jeong Tae Do; Caroline Desponts; Heung Sik Hahm; Hans R Schöler; Sheng Ding
Journal:  Cell Stem Cell       Date:  2008-06-05       Impact factor: 24.633

3.  Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.

Authors:  Frederick Anokye-Danso; Chinmay M Trivedi; Denise Juhr; Mudit Gupta; Zheng Cui; Ying Tian; Yuzhen Zhang; Wenli Yang; Peter J Gruber; Jonathan A Epstein; Edward E Morrisey
Journal:  Cell Stem Cell       Date:  2011-04-08       Impact factor: 24.633

4.  Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.

Authors:  Jacob Hanna; Marius Wernig; Styliani Markoulaki; Chiao-Wang Sun; Alexander Meissner; John P Cassady; Caroline Beard; Tobias Brambrink; Li-Chen Wu; Tim M Townes; Rudolf Jaenisch
Journal:  Science       Date:  2007-12-06       Impact factor: 47.728

5.  Human induced pluripotent stem cells free of vector and transgene sequences.

Authors:  Junying Yu; Kejin Hu; Kim Smuga-Otto; Shulan Tian; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

6.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

Authors:  Angel Raya; Ignasi Rodríguez-Pizà; Guillermo Guenechea; Rita Vassena; Susana Navarro; María José Barrero; Antonella Consiglio; Maria Castellà; Paula Río; Eduard Sleep; Federico González; Gustavo Tiscornia; Elena Garreta; Trond Aasen; Anna Veiga; Inder M Verma; Jordi Surrallés; Juan Bueren; Juan Carlos Izpisúa Belmonte
Journal:  Nature       Date:  2009-05-31       Impact factor: 49.962

7.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.

Authors:  Ryan Lister; Mattia Pelizzola; Yasuyuki S Kida; R David Hawkins; Joseph R Nery; Gary Hon; Jessica Antosiewicz-Bourget; Ronan O'Malley; Rosa Castanon; Sarit Klugman; Michael Downes; Ruth Yu; Ron Stewart; Bing Ren; James A Thomson; Ronald M Evans; Joseph R Ecker
Journal:  Nature       Date:  2011-02-02       Impact factor: 49.962

8.  Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy.

Authors:  Sara E Howden; Athurva Gore; Zhe Li; Ho-Lim Fung; Benjamin S Nisler; Jeff Nie; Goukai Chen; Brian E McIntosh; Daniel R Gulbranson; Nicole R Diol; Seth M Taapken; David T Vereide; Karen Dyer Montgomery; Kun Zhang; David M Gamm; James A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

9.  Disease-specific induced pluripotent stem cells.

Authors:  In-Hyun Park; Natasha Arora; Hongguang Huo; Nimet Maherali; Tim Ahfeldt; Akiko Shimamura; M William Lensch; Chad Cowan; Konrad Hochedlinger; George Q Daley
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582

10.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908
View more
  5 in total

Review 1.  Osteogenic differentiation of amniotic fluid mesenchymal stromal cells and their bone regeneration potential.

Authors:  Caterina Pipino; Assunta Pandolfi
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

Review 2.  Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs).

Authors:  Valentina Spinelli; Pascale V Guillot; Paolo De Coppi
Journal:  Organogenesis       Date:  2013-04-01       Impact factor: 2.500

Review 3.  CD117(+) amniotic fluid stem cells: state of the art and future perspectives.

Authors:  Mara Cananzi; Paolo De Coppi
Journal:  Organogenesis       Date:  2012-07-01       Impact factor: 2.500

4.  Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach.

Authors:  Dafni Moschidou; Sayandip Mukherjee; Michael P Blundell; Katharina Drews; Gemma N Jones; Hassan Abdulrazzak; Beata Nowakowska; Anju Phoolchund; Kenneth Lay; T Selvee Ramasamy; Mara Cananzi; Daniel Nettersheim; Mark Sullivan; Jennifer Frost; Gudrun Moore; Joris R Vermeesch; Nicholas M Fisk; Adrian J Thrasher; Anthony Atala; James Adjaye; Hubert Schorle; Paolo De Coppi; Pascale V Guillot
Journal:  Mol Ther       Date:  2012-07-03       Impact factor: 11.454

5.  Evaluating the Differential Effects of Valproic Acid on Wharton's Jelly Mesenchymal Stem Cells.

Authors:  Homa Salami; Seyed Javad Mowal; Rasoul Moukhah; Zahra Hajebrahimi; Seyed Abdolhakim Hosseini; Houri Edalat
Journal:  Adv Pharm Bull       Date:  2019-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.